SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-005694
Filing Date
2021-12-03
Accepted
2021-12-03 17:16:42
Documents
1
Period of Report
2021-12-01

Document Format Files

Seq Description Document Type Size
1 form4-12032021_021230.html 4  
1 form4-12032021_021230.xml 4 5763
  Complete submission text file 0001415889-21-005694.txt   7444
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 197 8TH STREET APARTMENT 804 CHARLESTOWN MA 02129
Business Address
Walts Alan Edmund (Reporting) CIK: 0001853544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 211471139